Your search returned 3 results.

Results
	1.	BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats. [electronic resource] by Bárdos, G Móricz, K Jaszlits, L Rabloczky, G Tory, K Rácz, I Bernáth, S Sümegi, B Farkas, B Literáti-Nagy, B Literáti-Nagy, P Producer: 20030724 In: Toxicology and applied pharmacology vol. 190 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders. [electronic resource] by Literáti-Nagy, B Péterfai, E Kulcsár, E Literáti-Nagy, Zs Buday, B Tory, K Mandl, J Sümegi, B Fleming, A Roth, J Korányi, L Producer: 20110224 In: Brain research bulletin vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. [electronic resource] by Literáti-Nagy, B Kulcsár, E Literáti-Nagy, Zs Buday, B Péterfai, E Horváth, T Tory, K Kolonics, A Fleming, A Mandl, J Korányi, L Producer: 20090803 In: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)